Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Ose Immunotherape News

    5,56 € -0,18% -0,01 €
    16:29:42 Uhr Tradegate aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A14QXP
    ISIN: FR0012127173
    US-Symbol: ORPOF
    Typ: Aktie

    Ose Immunotherape News

    27.03.24 - Businesswire
    OSE Immunotherapeutics Reports Full Year 2023 Financial Results and Provides Business Strategy Update
    Regulatory News:
    18.03.24 - Businesswire
    OSE Immunotherapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial Evaluating Lusvertikimab in Patients with Ulcerative Colitis
    Regulatory News:
    28.02.24 - Businesswire
    OSE Immunotherapeutics to Host a Live Webcast to Discuss AbbVie Global Partnership
    Regulatory News:
    28.02.24 - Businesswire
    AbbVie and OSE Immunotherapeutics Announce Partnership to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation
    Regulatory News:
    26.02.24 - Businesswire
    OSE Immunotherapeutics Provides Update on Clinical Results With OSE-279 in Advanced Solid Tumors
    Regulatory News:
    26.05.23 - DGAP
    OSE Immunotherapeutics (OSE): Re-initiation – Milestones anticipated throughout FY23
    Edison Investment Research Limited OSE Immunotherapeutics (OSE): Re-​initiation – Milestones anticipated throughout FY23 26-May-2023 / 07:15 GMT/BST The issuer is solely ...
    20.06.22 - Small- & Micro Cap Investment
    20.06.2022 Innocan Pharma: Internationaler Tag gegen Drogenmissbrauch am 26. Juni 2022
    Rund 5 Prozent aller Menschen zwischen 15 und 64 Jahren weltweit haben mindestens einmal Cannabis konsumiert* – das sind mehr Konsumenten als bei anderen Drogen. Doch ...
    06.12.18 - DGAP
    Edison initiates coverage on OSE Immunotherapeutics (OSE)
    Edison Investment Research Limited Edison initiates coverage on OSE Immunotherapeutics (OSE) 06-Dec-2018 / 15:06 GMT/BST
    29.03.16 - GlobeNewswire
    OSE Pharma to attend the Small & Midcap Event in Paris on 11 & 12 April, 2016
    OSE Pharma to attend the Small & Midcap Event in Paris on 11 & 12 April, 2016 Paris, March 29, 2016, 5:45 PM - OSE Pharma SA (ISIN: FR0012127173; Ticker: OSE), an immuno-...
    29.09.15 - GlobeNewswire
    OSE Pharma to participate to the Large & Midcap Event in Paris on October 7-8, 2015
    OSE Pharma to participate to the Large & Midcap Event in Paris on October 7-8, 2015 Paris, September 29th, 2015, 5:45 pm - OSE Pharma SA (ISIN : FR0012127173 ; Mnemo ...

    Newssuche

    Videos

    newspaper
    26.04.24 +7,61%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »